News | April 30, 2015

SCAI Announces 2015 Late-Breaking Clinical Trials

Subjects range from orbital atherectomy to platelet function testing

April 30, 2015 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the following late-breaking clinical trials to be presented at its 2015 Scientific Sessions, May 6-9 in San Diego:

Thursday, May 7, 11:45 a.m. to 12:15 p.m. Pacific Time

Session Moderators: Ted A Bass, M.D., FSCAI, and Gregg W. Stone, M.D., FSCAI

  • Orbital Atherectomy Treatment of Severely Calcified Coronary Lesions:  Two-Year Results of the ORBIT II Trial and Long-Term Economic Analysis, presented by Jeffrey Chambers, M.D., FSCAI
  • Ticagrelor versus Clopidogrel in Troponin-negative Patients with Acute Coronary Syndrome Undergoing Ad Hoc Percutaneous Coronary Intervention: Results of a Prospective, Randomized, Multicenter Pharmacodynamic Study, presented by Roxana Mehran, M.D., FSCAI
  • Impact of Combined Lipid Lowering with Calcium Channel Antagonist-based Blood Pressure Control on Coronary Plaque Regression: MILLION Study, presented by Masa-aki Kawashiri, M.D.


Friday, May 8, 9:00 a.m. to 9:30 a.m. Pacific Time

Session Moderators: Matthew Price, M.D., FSCAI, and Roxana Mehran, M.D., FSCAI

  • OUTSIDE START Cilostazol Bridging Study: 8-Year Experience with Outpatient Cilostazol Bridging in High Stent Thrombosis Risk Paclitaxel Drug-Eluting Stents in Patients Having Surgery During the Proven At-Risk Period, presented by Charles L. Laham, M.D., FSCAI 
  • 90 Day Effectiveness and Safety of Prasugrel vs. Clopidogrel as Used in Clinical Practice in Patients With ACS Undergoing PCI: Initial Findings from the PROMETHEUS Study, presented by Usman Baber, M.D.
  • Impact of an Integrated Treatment Algorithm Based on Platelet Function Testing and Clinical Risk Assessment: Results of the TRIAGE study, presented by George D. Dangas, M.D., Ph.D., FSCAI.


For more information:

Related Content

Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Clinical Study | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Clinical Study | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Clinical Study | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Clinical Study | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Clinical Study | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init